Accrued Expenses

3 Months Ended

Mar. 31, 2017

Accrued Expenses [Abstract]

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	March 31,  2017		December 31,  2016
Clinical trial expenses	$	993,334	$	741,174
Other		80,014		64,944
Total	$	1,073,348	$	806,118